These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 30136176

  • 1. Development and Characterisation of Modified Release Hard Gelatin Capsules, Based on In Situ Lipid Matrix Formation.
    Vasvári G, Csontos B, Sovány T, Regdon G, Bényei A, Váradi J, Bácskay I, Ujhelyi Z, Fehér P, Sinka D, Nguyen TLP, Vecsernyés M, Fenyvesi F.
    AAPS PharmSciTech; 2018 Oct; 19(7):3165-3176. PubMed ID: 30136176
    [Abstract] [Full Text] [Related]

  • 2. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K, Sistla R, Shastri NR.
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [Abstract] [Full Text] [Related]

  • 3. Rheological behavior of drug suspensions in Gelucire mixtures and proxyphylline release from matrix hard gelatin capsules.
    Ratsimbazafy V, Bourret E, Duclos R, Brossard C.
    Eur J Pharm Biopharm; 1999 Nov; 48(3):247-52. PubMed ID: 10612036
    [Abstract] [Full Text] [Related]

  • 4. Study of in-vitro release characteristics of carbamazepine extended release semisolid matrix filled capsules based on Gelucires.
    Galal S, El Massik MA, Abdallah OY, Daabis NA.
    Drug Dev Ind Pharm; 2004 Sep; 30(8):817-29. PubMed ID: 15521328
    [Abstract] [Full Text] [Related]

  • 5. Suitability of Gelucire 50/13 for controlled release formulation of salbutamol sulphate.
    Mohsin S, Rahman NU, Idrees MA, Sarfraz MK, Khan MK, Mustafa G.
    Pak J Pharm Sci; 2012 Jan; 25(1):35-41. PubMed ID: 22186307
    [Abstract] [Full Text] [Related]

  • 6. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM, Arida AI, Fahelelbom KM, Sadek B, Saeed DA, Abu Jarad RA, Jawadi J.
    Drug Dev Ind Pharm; 2015 Jan; 41(10):1726-37. PubMed ID: 25586554
    [Abstract] [Full Text] [Related]

  • 7. Significance of lipid matrix aging on in vitro release and in vivo bioavailability.
    Choy YW, Khan N, Yuen KH.
    Int J Pharm; 2005 Aug 11; 299(1-2):55-64. PubMed ID: 15955645
    [Abstract] [Full Text] [Related]

  • 8. Semisolid matrix filled capsules: an approach to improve dissolution stability of phenytoin sodium formulation.
    El Massik MA, Abdallah OY, Galal S, Daabis NA.
    Drug Dev Ind Pharm; 2003 May 11; 29(5):531-43. PubMed ID: 12779283
    [Abstract] [Full Text] [Related]

  • 9. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
    Wu Y, Zhao F, Paborji M.
    Pharm Dev Technol; 2003 May 11; 8(4):379-83. PubMed ID: 14601962
    [Abstract] [Full Text] [Related]

  • 10. Lipid Based Formulations in Hard Gelatin and HPMC Capsules: a Physical Compatibility Study.
    Koehl NJ, Shah S, Tenekam ID, Khamiakova T, Sauwen N, Vingerhoets S, Coppenolle H, Holm R.
    Pharm Res; 2021 Aug 11; 38(8):1439-1454. PubMed ID: 34378150
    [Abstract] [Full Text] [Related]

  • 11. Stabilization of hard gelatin capsule shells filled with polyethylene glycol matrices.
    Stein D, Bindra DS.
    Pharm Dev Technol; 2007 Aug 11; 12(1):71-7. PubMed ID: 17484146
    [Abstract] [Full Text] [Related]

  • 12. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
    Kuentz M, Rothenhäusler B, Röthlisberger D.
    Drug Dev Ind Pharm; 2006 Aug 11; 32(10):1165-73. PubMed ID: 17090439
    [Abstract] [Full Text] [Related]

  • 13. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK, Kołodziejska J, Zgoda MM.
    Polim Med; 2012 Aug 11; 42(2):121-32. PubMed ID: 23016443
    [Abstract] [Full Text] [Related]

  • 14. HPMC capsules: current status and future prospects.
    Al-Tabakha MM.
    J Pharm Pharm Sci; 2010 Aug 11; 13(3):428-42. PubMed ID: 21092714
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
    Hussein A, El-Menshawe S, Afouna M.
    Pharmazie; 2012 Mar 11; 67(3):209-14. PubMed ID: 22530301
    [Abstract] [Full Text] [Related]

  • 16. Use of texture analysis to study hydrophilic solvent effects on the mechanical properties of hard gelatin capsules.
    Mei X, Etzler FM, Wang Z.
    Int J Pharm; 2006 Nov 06; 324(2):128-35. PubMed ID: 16844327
    [Abstract] [Full Text] [Related]

  • 17. Gelatin and Non-Gelatin Capsule Dosage Forms.
    Gullapalli RP, Mazzitelli CL.
    J Pharm Sci; 2017 Jun 06; 106(6):1453-1465. PubMed ID: 28209365
    [Abstract] [Full Text] [Related]

  • 18. Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery.
    Zoubari G, Staufenbiel S, Volz P, Alexiev U, Bodmeier R.
    Eur J Pharm Biopharm; 2017 Jan 06; 110():39-46. PubMed ID: 27810471
    [Abstract] [Full Text] [Related]

  • 19. Effect of aging on the release of salbutamol sulfate from lipid matrices.
    San Vicente A, Hernández RM, Gascón AR, Calvo MB, Pedraz JL.
    Int J Pharm; 2000 Nov 04; 208(1-2):13-21. PubMed ID: 11064207
    [Abstract] [Full Text] [Related]

  • 20. Influence of Polymer Type on the Physical Properties and Release Profile of Papaverine Hydrochloride From Hard Gelatin Capsules.
    Polski A, Iwaniak K, Kasperek R, Modrzewska J, Sobótka-Polska K, Sławińska K, Poleszak E.
    Polim Med; 2015 Nov 04; 45(2):51-5. PubMed ID: 26994886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.